Table 3.
LTBI group (n = 68) | Non-LTBI group (n = 164) | P | |
---|---|---|---|
AST, n (%) | |||
≤1.5 Upper limit of normal | 9 (13.2) | 5 (3.0) | 0.006 |
≤2.0 Upper limit of normal | 2 (2.9) | 0 (0) | 0.078 |
>2.0 Upper limit of normal | 2 (2.9) | 0 (0) | 0.078 |
ALT, n (%) | |||
≤1.5 Upper limit of normal | 1 (1.5) | 9 (5.5) | 0.290 |
≤2.0 Upper limit of normal | 7 (10.3) | 5 (3.0) | 0.041 |
>2.0 Upper limit of normal | 9 (13.2) | 4 (2.4) | 0.002 |
eGFR, n (%) | |||
≤60 mL/min | 3 (4.4) | 3 (1.8) | 0.362 |
≤30 mL/min | 0 (0) | 0 (0) | >0.99 |
≤15 mL/min | 0 (0) | 0 (0) | >0.99 |
BD, Behçet’s disease; LTBI, latent tuberculosis infection; CNS, central nervous system; AST, aspartate transaminase; ALT, alanine transaminase; eGFR, estimated glomerular filtration rate. P < 0.05 was considered statistically significant was shown in bold.